# US 2008/0188650 A1 · Method for affinity chromatography of antithrombin iii

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188650 A1
- Document ID: US20080188650A1
- Status: Published application
- Kind: A1
- Application number: 12/020,787
- Filed: 2008-01-28
- Published: 2008-08-07
- Earliest claimed: 2005-07-27
- Assignees: Aventis Pharma S.A.
- Inventors: Pierre MOURIER; Gerald PERRET
- Web page: https://patentgrep.com/patent/US20080188650A1

## CPC

- B01J 20/3274: {Proteins, nucleic acids, polysaccharides, antibodies or antigens}
- B01D 15/3823: {of other types, e.g. avidin, streptavidin or biotin}
- B01J 20/286: Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J 20/3242: {Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group}
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)

## Abstract

The present invention is directed to an affinity chromatography column comprising the antithrombin III (ATIII) protein bound to a solid support, characterized in that: a. the ATIII protein is the wild-type protein or a variant thereof, b. the ATIII protein has been first activated by incubation with an unmodified low-molecular-weight heparin (LMWH) rich in active species, and c. the ATIII protein is covalently bound to a resin in a ratio of less than approximately 2 mg of protein per ml of hydrated resin. The invention is also directed to the use of the aforesaid column for purifying species having an affinity for ATIII in a sample comprising species having affinity and not having affinity for ATIII.

## Claims

### Claim 1

An affinity chromatography column comprising the antithrombin III (ATIII) protein bound to a solid support, characterized in that:
a. the ATIII protein is the wild-type protein or a variant thereof,
b. the ATIII protein has been first activated by incubation with an unmodified low-molecular-weight heparin (LMWH) rich in active species, and
c. the ATIII protein is covalently bound to a resin in a ratio of less than approximately 2 mg of protein per ml of hydrated resin.

### Claim 2 (depends on 1)

The column as defined in claim 1, characterized in that the ratio between the amounts of ATIII-binding sites present in LMWH and of ATIII molecules is between approximately 5 and approximately 15.

### Claim 3 (depends on 2)

The column as defined in claim 2, characterized in that this ratio is approximately 10.

### Claim 4 (depends on 1)

The column as defined in claim 1, characterized in that the LMWH is enoxaparine.

### Claim 5 (depends on 1)

The column as defined in claim 1, characterized in that the ATIII/resin ratio is between 0.5 and 1.5 mg of protein per ml of resin.

### Claim 6 (depends on 1)

A method for purifying species having affinity for ATIII in a sample comprising species having affinity and not having affinity for ATIII, said method comprising:
a. introducing said sample into the affinity chromatography column according to claim 1, said column being first equilibrated in an appropriate saline buffer;
b. washing the species not specifically retained from said column with an appropriate saline washing buffer, and
c. eluting the species specifically retained from said column with an appropriate saline eluting buffer.

### Claim 7 (depends on 6)

The method for purifying species having affinity for ATIII as claimed in claim 6, characterized in that said species are oligosaccharides.
